WeVote
Log In

Bill

Bill

H 833

An act relating to evaluating the feasibility of developing a public option, high-deductible health insurance plan

2025-2026 Regular Session Introduced by Michael Boutin

The bill directs a feasibility study to assess whether Vermont should develop a public health insurance option or a high-deductible plan, evaluating costs, impacts, and implementat

Read first time and referred to the Committee on Health Care
0
WeVote Research Nonpartisan
Bill Summary · H 833

Overview

House Bill H 833 (2025-2026, Vermont) is an act relating to evaluating the feasibility of developing a public option and a high-deductible health insurance plan. The bill, which received its first reading on January 29, 2026 and was referred to the Committee on Health Care, is sponsored with a co-sponsor: Michael Boutin. The measure focuses on studying and analyzing whether Vermont should establish a public health insurance option and a high-deductible plan, outlining the scope, criteria, and process for such an evaluation.

Purpose and intent

  • To determine whether Vermont should develop:
    • A public option for health insurance (a government-backed plan offered to residents as an alternative to private plans on the marketplace or within the state’s health system).
    • A high-deductible health insurance plan (HDHP) that might be paired with a health savings account (HSA) or similar structure, potentially aimed at reducing premium costs and widening plan choice.
  • To evaluate feasibility, including economic, administrative, regulatory, and health system implications.
  • To inform future legislative decisions on implementing one or both options based on the study’s findings.

Key provisions and changes (as described in the bill’s focus)

  • Commissioning or directing a feasibility study (or similar evaluative process) to assess:
    • Financial viability: projected costs, funding mechanisms, subsidies, impact on state budgets, and potential savings or expenditures for residents and employers.
    • Market impact: effects on private insurers, premiums, coverage choices, and competition.
    • Administrative framework: state roles, governance, oversight, eligibility rules, and enrollment processes.
    • Legal/regulatory considerations: federal waivers, compatibility with existing Medicaid/CHIP programs, and consumer protection measures.
    • Health outcomes and access: potential impact on access to care, choice, and affordability for Vermonters.
  • Possible timelines, milestones, and criteria for deciding whether to move from study to implementation.
  • Identification of stakeholders and mechanisms for public input during the evaluation process.

Note: The bill text provided here emphasizes the intent to evaluate feasibility. Specific policy design details (e.g., plan structures, funding sources, eligibility rules, or statutory changes) are typically fleshed out during the feasibility study and any subsequent legislative drafting, should the study indicate viability.

Who would be affected

  • Vermont residents who purchase health insurance (individuals and small businesses) could be impacted by any future public option or HDHP, including changes to premiums, coverage options, and access.
  • Private insurers operating in Vermont, which might experience changes in competition, pricing pressure, or product offerings.
  • The state government and through its health care administration, with potential administrative and regulatory adjustments if a public option or HDHP were pursued.
  • Healthcare providers and networks, indirectly affected by changes in payer mix and reimbursement dynamics.

Procedural and timeline aspects

  • Timetable: The bill has been read and referred to the House Committee on Health Care as of January 29, 2026. The typical subsequent steps involve committee hearings, potential amendments, and a committee vote before moving to the full House for debate.
  • Process: The core procedural path is to conduct a comprehensive feasibility evaluation, with findings guiding whether to draft more detailed legislation to implement a public option and/or HDHP.
  • Stakeholder engagement: Feasibility studies commonly include stakeholder input, expert analysis, and public comment periods to ensure a thorough assessment.

Potential impacts and considerations

  • Policymakers and the public will gain information on:
    • The economic practicality and potential cost to taxpayers and enrollees.
    • The administrative complexity and required regulatory changes.
    • The likely effects on insurance markets, pricing, and consumer choice.
    • Health equity and access implications for Vermonters.
  • The bill does not itself create a public option or HDHP but initiates a structured analysis to determine whether pursuing those concepts is viable.

If you’d like, I can tailor this summary to emphasize potential fiscal impact assumptions, likely stakeholder concerns, or provide a comparison with similar feasibility studies in other states.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.